Exelixis, Swedish Orphan Biovitrum sales and marketing update

Exelixis granted Swedish Orphan rights to distribute and commercialize Cometriq cabozantinib to treat metastatic medullary thyroid cancer (MTC) in the EU, Switzerland, Norway, Russia, Turkey and cert...